Cryptococcal meningitis
MONDO:0005723Meningeal inflammation produced by cryptococcus neoformans, an encapsulated yeast that tends to infect individuals with acquired immunodeficiency syndrome and other immunocompromised states. The organism enters the body through the respiratory tract, but symptomatic infections are usually limited to the lungs and nervous system. The organism may also produce parenchymal brain lesions (torulomas). Clinically, the course is subacute and may feature headache; nausea; photophobia; focal neurologic deficits; seizures; cranial neuropathies; and hydrocephalus. (From Adams et al., Principles of Neurology, 6th ed, pp721-2)
Also known as: Cryptococcus neoformans caused infectious meningitis, Cryptococcus neoformans infectious meningitis
15 clinical trials for this condition and its sub-types.
Follow this condition — get notified about new trialsBroader categories
-
NIH opens study to treat parasitic infections like malaria and worms
Disease control Recruiting nowThis study at the National Institutes of Health evaluates and treats people aged 3 and older with known or suspected parasitic infections, such as malaria, intestinal worms, and others. Participants receive standard medical care, not experimental treatments. The goal is to monito…
Sponsor: National Institute of Allergy and Infectious Diseases (NIAID) • Aim: Disease control
Last updated Jul 30, 2026 00:00 UTC
-
New hope against a deadly brain infection: large trial tests safer antifungals
Disease control Recruiting nowThis large platform trial is testing new antifungal drug combinations for cryptococcal meningitis, a severe brain infection that is fatal without treatment and common in people with HIV. The study will enroll 2,000 participants across multiple sites to compare a newer oral drug, …
Phase: PHASE2, PHASE3 • Sponsor: David Boulware • Aim: Disease control
Last updated Jul 29, 2026 00:00 UTC
-
Could a single shot stop deadly meningitis in HIV patients?
Disease control Recruiting nowThis study tests whether adding one dose of a stronger antifungal drug (liposomal amphotericin) to the standard treatment (fluconazole) can prevent cryptococcal meningitis in HIV-positive adults who test positive for the fungus but have no symptoms. About 356 participants in Ugan…
Phase: PHASE2, PHASE3 • Sponsor: Makerere University • Aim: Disease control
Last updated Jun 27, 2026 12:25 UTC
-
Scientists launch Long-Term study to unravel mysterious immune condition
Knowledge-focused Recruiting nowThis study follows 950 people with idiopathic CD4+ lymphocytopenia (ICL), a rare condition where low CD4+ white blood cells raise infection risk. Researchers will track participants for up to 10 years, collecting medical history, blood samples, and infection data. The goal is to …
Sponsor: National Institute of Allergy and Infectious Diseases (NIAID) • Aim: Knowledge-focused
Last updated Aug 18, 2026 06:00 UTC
-
Massive meningitis study aims to improve care in brazil
Knowledge-focused Recruiting nowThis study is tracking how adults with meningitis are treated in about 30 hospitals across Brazil. Researchers will follow 624 patients during their hospital stay and after discharge to see what treatments work best and how patients recover. The goal is to gather real-world evide…
Sponsor: Hospital Israelita Albert Einstein • Aim: Knowledge-focused
Last updated Aug 15, 2026 00:00 UTC
-
Why do healthy people get this fungal infection? new study aims to find out
Knowledge-focused Recruiting nowThis study looks at 800 healthy adults who have cryptococcosis, a fungal infection that usually only harms people with weak immune systems. Researchers want to learn why these otherwise healthy people get sick, how their immune system responds, and how the disease progresses over…
Sponsor: National Institute of Allergy and Infectious Diseases (NIAID) • Aim: Knowledge-focused
Last updated Aug 09, 2026 00:00 UTC
-
New rapid test could speed up sepsis diagnosis in ER
Knowledge-focused Recruiting nowThis study is testing a new rapid diagnostic device called In-Dx to quickly identify infections and antibiotic resistance in emergency patients with suspected sepsis. Researchers will compare the device's results to standard lab cultures using stored samples from 2,500 patients. …
Sponsor: Michigan State University • Aim: Knowledge-focused
Last updated Jun 27, 2026 13:05 UTC
-
New registry aims to improve meningitis treatment for kids
Knowledge-focused Recruiting nowThis study is creating a registry of 600 children under 18 with meningitis treated at hospitals across Brazil. Researchers will collect data during and after hospitalization to see how well current treatments work and what long-term problems, like hearing loss, occur. The goal is…
Sponsor: Hospital Israelita Albert Einstein • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:29 UTC
-
Massive meningitis study aims to save lives in uganda
Knowledge-focused Recruiting nowThis study in northern Uganda will track 1,100 people with meningitis symptoms and screen 10,000 HIV-positive patients for a fungal infection that can lead to meningitis. Researchers will use modern diagnostic tests to understand the causes and outcomes of the disease. The goal i…
Phase: NA • Sponsor: University of Rochester • Aim: Knowledge-focused
Last updated Jun 27, 2026 08:10 UTC